Colon Cancer - Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License
Earthtimes - PharmaSciences continues to progress its pipeline of products in women s health, inflammation and cancer, we ligand to be advanced into clinical development for a variety of cancers including breast, prostate and colon
HEALTH MATTERS: Super foods help fight disease
Packet Online - Diets rich in probiotics have been linked to a decrease in intestinal disorders such as diarrhea, constipation, irritable bowel syndrome and colon cancer.
Interactive Human Atlas:
WAVY News 10 - US cancer deaths up by 5,400 in 2005; death rate continues to fall among total population Young boy with a big heart, raises DISCLAIMER* : The information contained in or provided through this site section is intended for general consumer
‘Enormous Progress’ in Reducing Cancer Does Not Include Lung Cancer
Forbes - The five-year survival rate for breast cancer now stands at 88 percent, prostate cancer 99 percent and colon cancer 65 percent while lung cancer remains at 15 percent.
Levin calls for release of CDC report
Detroit News - The findings indicated that residents in those areas face higher risk of a variety of health threats, including infant mortality rates, low birth weights, breast cancer and colon cancer.